Evidence map›Paper›PMID 28438935›Full record

ArticleAntimicrobial agents and chemotherapy2017

Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.

Laura Judith Marcos-Zambrano, Mireia Puig-Asensio, Felipe Pérez-García, Pilar Escribano, Carlos Sánchez-Carrillo, Oscar Zaragoza, Belén Padilla, Manuel Cuenca-Estrella, Benito Almirante, M Teresa Martín-Gómez and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  5. Article
  6. Article
  7. Journal of clinical microbiology · 2024
    Article
  8. Article
  9. Article
  10. Diagnosis and Treatment Challenges ofCase reports in infectious diseases · 2024
    Article
  11. Article
  12. Emergence of cryptic species and clades ofMicrobiology spectrum · 2023
    Article
  13. Article
  14. Article
  15. Overview on the Infections Related to RarePathogens (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Frontiers in microbiology · 2022
    Article
  18. The Flo Adhesin Family.Pathogens (Basel, Switzerland) · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Laura Judith Marcos-ZambranoClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Mireia Puig-AsensioInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-0722-2218
Felipe Pérez-GarcíaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Pilar EscribanoClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Carlos Sánchez-CarrilloClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Oscar ZaragozaMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Belén PadillaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Manuel Cuenca-EstrellaMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Benito AlmiranteInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
M Teresa Martín-GómezMicrobiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Patricia MuñozClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Emilio BouzaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Jesús GuineaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain jguineaortega@yahoo.es.ORCID 0000-0002-7901-8355
Hospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ESUniversitat Autònoma de Barcelona · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objectives of our study were to describe the characteristics of patients with

Indexed as

AdolescentAdultAgedAntifungal AgentsBiofilmsCandidaCandidemiaChildDrug Resistance, FungalFemaleHumansMaleMicroscopy, Electron, ScanningMiddle AgedRetrospective StudiesVirulenceAntifungal Agentsbiofilm formationCandida fermentatiCandida guilliermondiiGalleria mellonellanon-albicans candidemia

Identifiers

PMID28438935
PMCPMC5487632
OpenAlexW2608505392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.